Chemoinformaics analysis of Hydroxy-gamma-Sanshool
| Molecular Weight | 289.419 | nRot | 9 |
| Heavy Atom Molecular Weight | 262.203 | nRig | 6 |
| Exact Molecular Weight | 289.204 | nRing | 0 |
| Solubility: LogS | -2.51 | nHRing | 0 |
| Solubility: LogP | 1.324 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 48 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 21 | No. of Aromatic Carbocycles | 0 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 27 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 18 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 50.7674 |
| nHD | 2 | BPOL | 28.5246 |
| QED | 0.639 |
| Synth | 3.428 |
| Natural Product Likeliness | 1.104 |
| NR-PPAR-gamma | 0.007 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.007 |
| Pgp-sub | 0.001 |
| HIA | 0.008 |
| CACO-2 | -4.283 |
| MDCK | 0.0000227 |
| BBB | 0.807 |
| PPB | 0.845948 |
| VDSS | 1.176 |
| FU | 0.108719 |
| CYP1A2-inh | 0.101 |
| CYP1A2-sub | 0.155 |
| CYP2c19-inh | 0.337 |
| CYP2c19-sub | 0.406 |
| CYP2c9-inh | 0.298 |
| CYP2c9-sub | 0.9 |
| CYP2d6-inh | 0.588 |
| CYP2d6-sub | 0.8 |
| CYP3a4-inh | 0.583 |
| CYP3a4-sub | 0.166 |
| CL | 7.416 |
| T12 | 0.753 |
| hERG | 0.441 |
| Ames | 0.166 |
| ROA | 0.662 |
| SkinSen | 0.969 |
| Carcinogencity | 0.593 |
| EI | 0.164 |
| Respiratory | 0.965 |
| NR-Aromatase | 0.006 |
| Antiviral | Yes |
| Prediction | 0.733513 |